Interstitial Lung Disease
‘Aggressive’ treatment of GERD improves survival in systemic sclerosis with ILD
“Aggressive” combination therapy for gastroesophageal reflux disease improved survival among patients with systemic sclerosis and interstitial lung disease, according to data published in Arthritis Research & Therapy.
Body surface area linked to nintedanib dose disruption in fibrotic ILD
Increased body surface area lowered the likelihood for nintedanib dose reduction/discontinuation among patients with fibrotic interstitial lung disease, according to results published in Respiratory Medicine.
IPF-related mortality rates differ based on urban, rural areas
Individuals living in medium/small metropolitan and rural areas had increased idiopathic pulmonary fibrosis-related mortality rates vs. those living in large metropolitan areas, according to results published in CHEST.
Buloxibutid well tolerated, increases lung function in IPF
SAN DIEGO — Among patients with idiopathic pulmonary fibrosis, twice-daily buloxibutid for 36 weeks significantly improved FVC, according to research presented at the American Thoracic Society International Conference.
Hedgehog pathway inhibitor safe, improves lung function in IPF
SAN DIEGO — After receiving a hedgehog pathway inhibitor for 12 weeks, adults with idiopathic pulmonary fibrosis had better lung function, according to research presented at the American Thoracic Society International Conference.
Patients with IPF experience similar 48-week FVC declines with pamrevlumab, placebo
SAN DIEGO — The absolute change in FVC at 48 weeks was similar between patients with idiopathic pulmonary fibrosis receiving pamrevlumab vs. placebo, according to a presentation at the American Thoracic Society International Conference.
‘Be aggressive’ in detecting, managing interstitial lung disease in early scleroderma
DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and aggressive action, according to data presented at the Congress of Clinical Rheumatology East.
ILD diagnosis step-up strategy can ‘mitigate patient and health care system burdens’
The diagnostic yield for interstitial lung disease was comparable between immediate surgical lung biopsy and a strategy that began with transbronchial cryobiopsy, according to results published in The Lancet Respiratory Medicine.
'Full cancer screening' essential for patients of all ages with dermatomyositis
DESTIN, Fla. — Although the strongest predictor of malignancy in dermatomyositis is age, all adult patients should undergo cancer screening, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.
VIDEO: Keeping patients at the center of care essential in metastatic breast cancer
Paolo Tarantino, MD, discusses the role of collaborative management of patients with metastatic breast cancer.